Porovnat metody
Prohlédněte si vybrané metody vedle sebe; řádky, které se liší, jsou zvýrazněny.
| Dotazník komunitní integrace× | Dopad na participaci a autonomii× | |
|---|---|---|
| Obor | Rehabilitační vědy | Rehabilitační vědy |
| Rodina | Process / pipeline | Process / pipeline |
| Rok vzniku≠ | 1993 | 2001 |
| Tvůrce≠ | Willer, Rosenthal, Kreutzer, Gordon | Cardol, de Haan, de Groot, de Jong |
| Typ≠ | Self-report or Clinician-administered | Self-report or Proxy |
| Původní zdroj≠ | Willer, B., Rosenthal, M., Kreutzer, J. S., Gordon, W. A., & Rempel, R. (1993). Assessment of community integration following rehabilitation for traumatic brain injury. Journal of Head Trauma Rehabilitation, 9(2), 75–87. link ↗ | Cardol, M., de Haan, R. J., de Jong, B. A., van den Bos, G. A., & de Groot, I. J. (2001). Psychometric properties of the Impact on Participation and Autonomy questionnaire. Archives of Physical Medicine and Rehabilitation, 82(2), 210–216. link ↗ |
| Další názvy | CIQ, CIQ-3 | IPA, IPA-Scale |
| Příbuzné | 5 | 5 |
| Shrnutí≠ | The Community Integration Questionnaire (CIQ) is a brief, validated instrument specifically designed to assess how well individuals with brain injury, spinal cord injury, or other disabling conditions have reintegrated into community life across home, social, and work domains. Originally developed in 1993 by Willer and colleagues, it operationalizes the WHO definition of 'participation' and has become the standard outcome measure in traumatic brain injury (TBI) rehabilitation and long-term follow-up studies. | The Impact on Participation and Autonomy (IPA) scale is a validated, patient-centered measure designed to quantify how chronic conditions or disabilities affect an individual's autonomy and participation in five key life domains: autonomy, mobility, occupation, social relations, and recreation. Developed in the Netherlands by Cardol and colleagues, it operationalizes the WHO handicap concept (now called 'participation restriction') and is widely used in rehabilitation, chronic disease management, and policy evaluation across Europe. |
| ScholarGateDatová sada ↗ |
|
|